See also this year's filing and all EDGAR filings for this company.
PDF Report 0001621221_2020_Artelo_Biosciences_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001621221, Artelo Biosciences INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,442,588 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,039,417 |
| 2 | PropertyPlantAndEquipmentNet | 721 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 1,021,513 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,169,458 |
| 9 | ResearchAndDevelopmentExpense | 1,109,695 |
| 10 | remainder_Expenses | 4,061,993 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 6,088,487 |
| 13 | remainder_ComprehensiveNetIncome | -12,936 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 6,482,726 |
| 1 | Liabilities | 1,021,513 |
| 2 | Expenses | 8,341,146 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 5,461,213 |
| 5 | NetIncome | -2,252,659 |
| 6 | ComprehensiveNetIncome | -2,259,127 |
| 7 | BaseVar | 10,973,404 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.57 |
| 9 | EconomicCapitalRatio | 3.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
